Princess Dina Mired, Past President of the Union for International Cancer Control, Member of WHO Expert Technical Group for the Elimination of Cervical Cancer, shared a post on X:
“New Episode Release Watch now:
- What if the most powerful weapon against cancer is already within us?
- With the rise of immunotherapy, how can our own immune system be activated to fight cancer?
- What happens when scientific breakthroughs move faster than the systems meant to deliver them?
- And what happens when scientific breakthroughs outpace access, equity, and public understanding?
Princess Dina sits down with Dr. Garo Armen, Chairman and CEO of Agenus, to explore the promise and limits of immunotherapy. But beyond the science, this conversation confronts a critical question: Why do life-saving innovations often take years – sometimes decades – to reach the patients who need them most?
Together, they examine how regulatory complexity, bureaucratic processes, and fragmented health systems can unintentionally delay access to new treatments – turning scientific progress into a slower, uneven reality for patients around the world.
Their conversation covers:
- How immunotherapy is the next frontier for curing cancer
- Why cancer is not one disease – and why no single cure exists
- Breakthrough cases where patients once considered incurable are now disease-free
- The truth behind viral claims – cancer vaccines, miracle cures, and misinformation
- Why progress in cancer treatment is only ‘50% of the way there’
How regulation and bureaucracy can delay patient access to life-saving therapies
The need to balance speed, safety, and responsibility in bringing treatments to market
The widening gap between innovation and access across the world
Why ‘precision without equity is not progress – it is privilege.’
A powerful conversation at the intersection of science, truth, and justice.
Presented by OncoDailyNews ”
Reinforcing the themes of the podcast, Agenus shared on LinkedIn:
“Garo Armen, Chairman and CEO of Agenus, recently joined Princess Dina on her podcast for a wide-ranging conversation on the promise of immunotherapy and the urgent need to improve how scientific innovation reaches patients.
The discussion explores the evolution of cancer immunotherapy, the challenge of cold tumors, the role of combination approaches, and the broader barriers that can delay patient access to potentially life-changing advances.
At Agenus, we remain committed to advancing immuno-oncology with a focus on reaching patients and tumor types that have not benefited enough from today’s therapies.
Watch the full conversation, now available on the Agenus website and below.”
Other articles about Immunotherapy on OncoDaily.